Overview / Abstract: |
Target Audience This activity is intended for allergists, immunologists, pulmonologists, primary care physicians, physician assistants, and other healthcare providers who care for patients with severe eosinophilic asthma. Program Overview The goal of this activity is to leverage a point-of-care tool along with expert commentary to improve the competence and performance of learners in diagnosing, assessing, and treating patients with severe eosinophilic asthma. Learning Objectives Upon completion of this activity, participants should be able to: Select a biologic-based treatment strategy that targets the proinflammatory mechanisms of severe eosinophilic asthma |
Expiration |
Aug 04, 2021 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.25 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Michael E. Wechsler, MD, MMSc Bradley E. Chipps, MDFAAP, FACAAI, FAAAAI, FCCP Nicola Alexander Hanania, MD, MS Linda Rogers, MD Eileen Wang, MD, MPH |
Sponsors / Supporters / Grant Providers |
Novartis Pharmaceuticals Corporation, Sanofi Genzyme, and Regeneron Pharmaceuticals. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Asthma Free CE CME |